Applied DNA Sciences, Inc. UDJP.F Stock
Applied DNA Sciences, Inc. Price Chart
Applied DNA Sciences, Inc. UDJP.F Financial and Trading Overview
Applied DNA Sciences, Inc. stock price | 0.35 EUR |
Previous Close | 1.19 EUR |
Open | 1.19 EUR |
Bid | 1.19 EUR x N/A |
Ask | 1.24 EUR x N/A |
Day's Range | 1.19 - 1.19 EUR |
52 Week Range | 0.65 - 6.25 EUR |
Volume | 640 EUR |
Avg. Volume | 65 EUR |
Market Cap | 15.58M EUR |
Beta (5Y Monthly) | 0.458098 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.51 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 17.67 EUR |
UDJP.F Valuation Measures
Enterprise Value | 4.74M EUR |
Trailing P/E | N/A |
Forward P/E | -1.2040404 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.88920915 |
Price/Book (mrq) | 1.5380646 |
Enterprise Value/Revenue | 0.27 |
Enterprise Value/EBITDA | -0.488 |
Trading Information
Applied DNA Sciences, Inc. Stock Price History
Beta (5Y Monthly) | 0.458098 |
52-Week Change | 30.22% |
S&P500 52-Week Change | 20.43% |
52 Week High | 6.25 EUR |
52 Week Low | 0.65 EUR |
50-Day Moving Average | 1.01 EUR |
200-Day Moving Average | 1.45 EUR |
UDJP.F Share Statistics
Avg. Volume (3 month) | 65 EUR |
Avg. Daily Volume (10-Days) | 274 EUR |
Shares Outstanding | 12.91M |
Float | 11.98M |
Short Ratio | N/A |
% Held by Insiders | 1.39% |
% Held by Institutions | 15.88% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:40 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | September 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | September 30, 2023 |
Profitability
Profit Margin | -28.77% |
Operating Margin (ttm) | -62.94% |
Gross Margin | 32.18% |
EBITDA Margin | -55.34% |
Management Effectiveness
Return on Assets (ttm) | -41.71% |
Return on Equity (ttm) | -57.70% |
Income Statement
Revenue (ttm) | 17.53M EUR |
Revenue Per Share (ttm) | 1.52 EUR |
Quarterly Revenue Growth (yoy) | -28.29% |
Gross Profit (ttm) | 5.05M EUR |
EBITDA | -9699665 EUR |
Net Income Avi to Common (ttm) | -5042469 EUR |
Diluted EPS (ttm) | -0.29 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 12.29M EUR |
Total Cash Per Share (mrq) | 0.95 EUR |
Total Debt (mrq) | 1.47M EUR |
Total Debt/Equity (mrq) | 14.75 EUR |
Current Ratio (mrq) | 4.207 |
Book Value Per Share (mrq) | 0.775 |
Cash Flow Statement
Operating Cash Flow (ttm) | -7181644 EUR |
Levered Free Cash Flow (ttm) | -3942251 EUR |
Profile of Applied DNA Sciences, Inc.
Country | Germany |
State | NY |
City | Stony Brook |
Address | 50 Health Sciences Drive |
ZIP | 11790 |
Phone | 631 240 8800 |
Website | https://www.adnas.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 61 |
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR)-based MDx testing services for the Monkeypox virus; and MDx test kits and related supplies, as well as validates pharmacogenetics (PGx) testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, leather, pharmaceuticals, nutraceuticals, and other products; SigNify IF portable DNA readers and SigNify consumable reagent test kits, which offers a front-line solution for supply chain integrity backed with forensic-level molecular tag authentication; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Q&A For Applied DNA Sciences, Inc. Stock
What is a current UDJP.F stock price?
Applied DNA Sciences, Inc. UDJP.F stock price today per share is 0.35 EUR.
How to purchase Applied DNA Sciences, Inc. stock?
You can buy UDJP.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Applied DNA Sciences, Inc.?
The stock symbol or ticker of Applied DNA Sciences, Inc. is UDJP.F.
Which industry does the Applied DNA Sciences, Inc. company belong to?
The Applied DNA Sciences, Inc. industry is Diagnostics & Research.
How many shares does Applied DNA Sciences, Inc. have in circulation?
The max supply of Applied DNA Sciences, Inc. shares is 17.28M.
What is Applied DNA Sciences, Inc. Price to Earnings Ratio (PE Ratio)?
Applied DNA Sciences, Inc. PE Ratio is now.
What was Applied DNA Sciences, Inc. earnings per share over the trailing 12 months (TTM)?
Applied DNA Sciences, Inc. EPS is -0.51 EUR over the trailing 12 months.
Which sector does the Applied DNA Sciences, Inc. company belong to?
The Applied DNA Sciences, Inc. sector is Healthcare.